Burn Care Market Growth Driven by Biotech Advances

By HospiMedica staff writers
Posted on 10 Dec 2007
A new report projects that the worldwide burn treatment market will experience fluctuating growth due to price constraints, new technologies, and additional market penetration.

A new report by Kalorama Information (New York, NY, USA) has found that conventional, mature products continue to dominate the global burn care market. However, their growth rate is slow and limited by the maturity of the product and the competition. A steady market growth is predicted due to advancements in biotechnology, biomaterials, and an increasing availability of new therapeutic techniques that result in decreasing healing times and subsequent cost savings.

Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience any type of burn, and the numerous products currently in development appear to be the key to successful growth in this market.

"As the wound care markets mature, partnerships are becoming more prevalent as a means of staving off the status quo,” said report author Kalorama analyst Mary Anne Crandall. "Competitors that offer traditional mature products must look for ways to incorporate advanced wound care products for treating burns into their existing products or to improve the existing products significantly to remain competitive with emerging technologies.”

Kalorama Information predicts that the worldwide burn care market will grow from U.S.$1.9 billion in 2006 to $2.5 billion by the year 2011.


Related Links:
Kalorama Information

Latest Critical Care News